Shopping Cart (0)
My Account

 Shopping Cart
Conferences | Training Courses | Market Reports | Managed Events | Past Conferences | Update Me
SELECTBIO Conferences Lab-on-a-Chip and Microfluidics: Companies, Technologies and Commercialization
Conferences  \  Lab-on-a-Chip & Microfluidics World Congress 2017  \  Lab-on-a-Chip and Microfluidics: Companies, Technologies and Commercialization  \  Agenda  \  Alexios Tzannis
RegisterLogin

Alexios Tzannis's Biography


Alexios Tzannis, Business Development Manager Life Sciences, IMT Microtechnologies

Dr. Alexios Paul Tzannis has been working for IMT for 12 years and is responsible for developing the Life Science and Diagnostics activities of IMT AG. He studied Electrical Engineer M.Sc. at the technical University of Denmark (DTU) in the field of technical Holography. He received his Ph.D. at the ETH Zurich for his work at Paul Scherrer Institute in the field of resonant holographic Interferometry. Dr. Alexios Paul Tzannis has founded, hands-on experience in Micro- and Nanotechnology, MEMS, Optics and Optoelectronics, Spectroscopy, and Microfluidics.

Alexios Tzannis Image

Picking the Right Microfluidics Device Material for In Vitro Diagnostics - Balancing Performance and Cost with Scalable Wafer Level Production of Consumables Made of Non-CMOS Compatible Materials on Glass

Tuesday, 3 October 2017 at 11:15

Add to Calendar ▼2017-10-03 11:15:002017-10-03 12:15:00Europe/LondonPicking the Right Microfluidics Device Material for In Vitro Diagnostics - Balancing Performance and Cost with Scalable Wafer Level Production of Consumables Made of Non-CMOS Compatible Materials on GlassSELECTBIOenquiries@selectbiosciences.com

IMT offers leading edge technologies with automated and standardized processes to fabricate components in glass for In Vitro Diagnostics (IVD). The high integration level and cross disciplinary character of IVD is determined by the complex biology and assay deployment and the instrumentation. Microfluidics, a multidisciplinary field characterized by the precise control and manipulation of fluids constrained to a sub-millimetre scale, has shown considerable promise for improving diagnostics and biology research. Certain properties of microfluidic technologies, such as rapid sample processing and the precise control of fluids in an assay, have made them attractive candidates to replace traditional experimental approaches. In this paper we discuss the challenges and solutions of implementing wafer-level packaging (WLP) processes for IVD products.

Add to Calendar ▼2017-10-02 00:00:002017-10-04 00:00:00Europe/LondonLab-on-a-Chip and Microfluidics: Companies, Technologies and CommercializationSELECTBIOenquiries@selectbiosciences.com


Corporate Sponsors